ELVN
Enliven Therapeutics Inc.
Company Overview
| Mkt Cap | $1.12B | Price | $23.42 |
| Volume | 388.07K | Change | -2.29% |
| P/E Ratio | -12.6 | Open | $23.88 |
| Revenue | -- | Prev Close | $23.97 |
| Net Income | $-89.0M | 52W Range | $13.30 - $29.79 |
| Div Yield | N/A | Target | $41.25 |
| Overall | 54 | Value | 60 |
| Quality | 36 | Technical | 66 |
No chart data available
Stock Overview
Updated DailyEnliven Therapeutics Inc. (ELVN) is a leading diversified company in the business industry, currently trading at $23.42 with a market capitalization of $1.12 billion. The stock is positioned in the upper portion of its trading range, demonstrating concerning quality fundamentals with a MarketXLS quality score of 36.
Today's trading session shows ELVN with a volume of 388K shares. The stock opened down 0.38% from yesterday's close of $23.97. Current analyst estimates project earnings of $-1.95 per share for this year, with next year targeting $-2.19.
ELVN demonstrates positive technical signals based on technical analysis. The company trades on the NGS exchange.
Key investment considerations for ELVN include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 76.1%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 07:16 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ELVN | $23.42 | -2.3% | 388.07K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Enliven Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW